ArticleFrontiers in radiology2025
Federated radiomics analysis of preoperative MRI across institutions: toward integrated glioma segmentation and molecular subtyping.
Article in Frontiers in radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-invasive and comprehensive molecular characterization of glioma is crucial for personalized treatment but remains limited by invasive biopsy procedures and stringent privacy restrictions on clinical data sharing. Federated learning (FL) provides a promising solution by enabling multi-institutional collaboration without compromising patient confidentiality. Methods: We propose a multi-task 3D deep neural network framework based on federated learning. Using multi-modal MRI images, without sharing the original data, the automatic segmentation of T2w high signal region and the prediction of four molecular markers (IDH mutation, 1p/19q co-deletion, MGMT promoter methylation, WHO grade) were completed in collaboration with multiple medical institutions. We trained the model on local patient data at independent clients and aggregated the model parameters on a central server to achieve distributed collaborative learning. The model was trained on five public datasets ( Results: The model showed good performance in the external test set (IDH AUC = 0.88, 1p/19q AUC = 0.84, MGMT AUC = 0.85, grading AUC = 0.94), and the median Dice of the segmentation task was 0.85. Conclusions: Our federated multi-task deep learning model demonstrates the feasibility and effectiveness of predicting glioma molecular characteristics and grade from multi-parametric MRI, without compromising patient privacy. These findings suggest significant potential for clinical deployment, especially in scenarios where invasive tissue sampling is impractical or risky.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.